Cargando…

Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists

SIMPLE SUMMARY: Patients with venous thromboembolism events in the context of cancer should receive anticoagulants for at least 6 months. Both low molecular weight heparins (LMWHs) and direct oral anticoagulants (DOACs) are considered in international guidelines, with a different approach. To invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahé, Isabelle, Chapelle, Céline, Plaisance, Ludovic, Bertoletti, Laurent, Mismetti, Patrick, Mayeur, Didier, Mahé, Guillaume, Couturaud, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454850/ https://www.ncbi.nlm.nih.gov/pubmed/36077680 http://dx.doi.org/10.3390/cancers14174143

Ejemplares similares

Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study
por: Mahé, Isabelle, et al.
Publicado: (2020)

Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study
por: Plaisance, Ludovic, et al.
Publicado: (2021)

Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database
por: Couturaud, F., et al.
Publicado: (2023)

Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists
por: Bosquet, Antoine, et al.
Publicado: (2022)

In Search of the Appropriate Anticoagulant-Associated Bleeding Risk Assessment Model for Cancer-Associated Thrombosis Patients
por: Poénou, Géraldine, et al.
Publicado: (2022)

Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
por: Poenou, Géraldine, et al.
Publicado: (2022)

Low Molecular Weight Heparin Treatment Patterns and Outcomes in Cancer Patients with Acute Venous Thromboembolism: A Nationwide Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2023)

Protected adults’ voting rights: an interdisciplinary study of medical assessment and jurisprudence in France
por: Bosquet, Antoine, et al.
Publicado: (2018)

Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation
por: Lega, Jean-Christophe, et al.
Publicado: (2014)

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
por: Mahé, Isabelle, et al.
Publicado: (2019)

Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
por: Lanéelle, D., et al.
Publicado: (2021)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry
por: Debourdeau, Philippe, et al.
Publicado: (2023)

The underrecognized prothrombotic vascular disease of COVID‐19
por: Cohoon, Kevin P., et al.
Publicado: (2020)

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022)

Resilience in Arts and Cultural Nonprofit Organizations: An Analysis of the Covid-19 Crisis in France
por: Plaisance, Guillaume
Publicado: (2022)

The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
por: Omarjee, Loukman, et al.
Publicado: (2017)

Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study
por: Coudeville, Laurent, et al.
Publicado: (2021)

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
por: Moik, Florian, et al.
Publicado: (2021)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Herpes zoster in children during the COVID-19 pandemic in France: A retrospective multicenter observational study
por: Tabet, A., et al.
Publicado: (2023)

Severe arterial thrombosis associated with Covid-19 infection
por: Kashi, Mahine, et al.
Publicado: (2020)

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
por: Poenou, Géraldine, et al.
Publicado: (2023)

Inter-rater Reliability of a 13-Category Arterial Doppler Waveform Classification and Practice of French Vascular Physicians
por: Lanéelle, Damien, et al.
Publicado: (2021)

LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey
por: Keeley, Vaughan, et al.
Publicado: (2019)

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
por: Couturaud, Francis, et al.
Publicado: (2019)

Can big data increase our knowledge of local rental markets? A dataset on the rental sector in France
por: Chapelle, Guillaume, et al.
Publicado: (2022)

Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued
por: Mayenga, Marie, et al.
Publicado: (2023)

Use of a Pre-Trained Neural Network for Automatic Classification of Arterial Doppler Flow Waveforms: A Proof of Concept
por: Guilcher, Antoine, et al.
Publicado: (2021)

Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
por: Janisset, Luc, et al.
Publicado: (2022)

Obstructive Sleep Apnea, Hypercoagulability, and the Blood–Brain Barrier
por: Zolotoff, Cindy, et al.
Publicado: (2021)

A minimal resting time of 25 min is needed before measuring stabilized blood pressure in subjects addressed for vascular investigations
por: Mahe, Guillaume, et al.
Publicado: (2017)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
por: Gerotziafas, Grigoris T, et al.
Publicado: (2014)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Tumor Genetics Are Thrombogenic: The Need for Action
por: Mahé, Isabelle, et al.
Publicado: (2023)

The National Specialists’ Associations
Publicado: (1890)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France
por: Cloitre, Alexandra, et al.
Publicado: (2019)

Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
por: Mahé, Emmanuel
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_97fr42jmhmg7b3j18b95l3c5vl